Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer Posted on March 21, 2024 (March 20, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer
Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases Posted on March 19, 2024 (March 18, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases
ASIT Boston – 2024 | A Tolerizing APC-Targeted Vaccibody Vaccine Ameliorates Disease in Mouse Models of Experimental Autoimmune Encephalomyelitis and Non-Obese Diabetes Posted on March 19, 2024 (March 19, 2024) by Alexandra Deschner […] Read More… from ASIT Boston – 2024 | A Tolerizing APC-Targeted Vaccibody Vaccine Ameliorates Disease in Mouse Models of Experimental Autoimmune Encephalomyelitis and Non-Obese Diabetes
Nykode Therapeutics – 4Q 2023 Financial Results – presentation Posted on February 28, 2024 (February 28, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics – 4Q 2023 Financial Results – presentation
Nykode Therapeutics – 4Q 2023 Financial Results – webcast Posted on February 28, 2024 (February 27, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics – 4Q 2023 Financial Results – webcast
Nykode Therapeutics reports 4Q 2023 Financial Results Posted on February 28, 2024 (February 27, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics reports 4Q 2023 Financial Results
Nykode Therapeutics – 4Q 2023 Financial Results Posted on February 28, 2024 (February 27, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics – 4Q 2023 Financial Results
Nykode Therapeutics – invitation to Q4 2023 financial results presentation Posted on February 22, 2024 (February 21, 2024) by Alexandra Deschner […] Read More… from Nykode Therapeutics – invitation to Q4 2023 financial results presentation
42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 – presentation Posted on January 10, 2024 (January 16, 2024) by Alexandra Deschner […] Read More… from 42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 – presentation
42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 – webcast Posted on January 10, 2024 (January 16, 2024) by Alexandra Deschner […] Read More… from 42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 – webcast